Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intratympanic Injections”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Testing effectiveness (Phase 2)UnknownNCT01108601
What this trial is testing

Transtympanic Ringer's Lactate for the Prevention of Cisplatin Ototoxicity

Who this might be right for
Hearing Loss
McGill University Health Centre/Research Institute of the McGill University Health Centre 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT06878599
What this trial is testing

Intratympanic Injection of Dexamethasone With Hyaluronic Acid in Treatment of Sudden Sensorineural Hearing Loss

Who this might be right for
Sudden Sensorineural Hearing Loss (SSNHL)
Assiut University 70
Early research (Phase 1)Study completedNCT04601909
What this trial is testing

FX-322 in Adults With Age-Related Sensorineural Hearing Loss

Who this might be right for
PresbycusisHearing Loss, SensorineuralNoise Induced Hearing Loss+1 more
Frequency Therapeutics 30
Large-scale testing (Phase 3)Ended earlyNCT02706730
What this trial is testing

A 6-Month Extension Study of OTO-104 in Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 189
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07404709
What this trial is testing

Study on the Safety and Efficacy of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Stem Cells in Severe and Profound Sudden Sensorineural Hearing Loss

Who this might be right for
Sudden Hearing LossExtracellular Vesicles
The Affiliated Hospital of Qingdao University 9
Testing effectiveness (Phase 2)UnknownNCT04291209
What this trial is testing

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Who this might be right for
Ototoxic Hearing Loss
Sunnybrook Health Sciences Centre 80
Early research (Phase 1)Ended earlyNCT05664100
What this trial is testing

First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss

Who this might be right for
Hearing Loss, Sensorineural
Frequency Therapeutics 6
Testing effectiveness (Phase 2)WithdrawnNCT06437054
What this trial is testing

Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss

Who this might be right for
Hearing Loss, SensorineuralHearing Loss, SuddenIntratympanic Injection
Seoul National University Hospital
Large-scale testing (Phase 3)Study completedNCT02612337
What this trial is testing

Study of OTO-104 in Subjects With Unilateral Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 166
Large-scale testing (Phase 3)Ended earlyNCT02717442
What this trial is testing

Study of OTO-104 in Subjects With Unilateral Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 176
Testing effectiveness (Phase 2)Study completedNCT02265393
What this trial is testing

A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United Kingdom

Who this might be right for
Meniere's Disease
Otonomy, Inc. 128
Very early researchUnknownNCT04794842
What this trial is testing

Comparing Topical Tetracaine Drops to Topical Focal Phenol for Local Anesthesia During Intratympanic Steroid Injection

Who this might be right for
Intratympanic Steroid InjectionIdiopathic Sudden Sensorineural Hearing LossMeniere Disease
Our Lady of the Lake Hospital 80
Testing effectiveness (Phase 2)Ended earlyNCT02740387
What this trial is testing

Open Label Study of OTO-104 in Subjects With Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 34
Large-scale testing (Phase 3)Study completedNCT03664674
What this trial is testing

Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease

Who this might be right for
Meniere Disease
Otonomy, Inc. 148
Not applicableUnknownNCT03371589
What this trial is testing

Intratympanic Stereoidal Injections for Facial Nerve Palsy

Who this might be right for
Bell Palsy
Hillel Yaffe Medical Center 30
Testing effectiveness (Phase 2)Ended earlyNCT01526174
What this trial is testing

Intratympanic Injection for Autoimmune Inner Ear Disease

Who this might be right for
Autoimmune Inner Ear Disease
House Research Institute 16
Testing effectiveness (Phase 2)Study completedNCT04120116
What this trial is testing

FX-322 in Adults With Stable Sensorineural Hearing Loss

Who this might be right for
Sensorineural Hearing LossNoise Induced Hearing LossSudden Sensorineural Hearing Loss
Frequency Therapeutics 95
Not applicableNot Yet RecruitingNCT06213415
What this trial is testing

Role of Oral Steroid Alone Versus Oral Steroid Plus Intratympanic Steroid Injection in Bell's Palsy

Who this might be right for
Bell Palsy
Assiut University 42
Testing effectiveness (Phase 2)Study completedNCT04129775
What this trial is testing

OTO-413 in Subjects With Speech-in-Noise Hearing Impairment

Who this might be right for
Sensorineural Hearing Loss
Otonomy, Inc. 110
Post-approval studies (Phase 4)Study completedNCT01372904
What this trial is testing

Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment

Who this might be right for
Cisplatin Ototoxicity
Meir Medical Center 30
Next Page